Tagar Esteem, Kpolugbo James, Okomayin Andrew A, Tagar Afokeoghene G
Department of Surgery, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Surgery, Ambrose Alli University, Ekpoma, Nigeria.
Breast Cancer (Auckl). 2025 Mar 12;19:11782234251323774. doi: 10.1177/11782234251323774. eCollection 2025.
The surgical management of breast cancer involves either modified radical mastectomy or a conservative approach. Breast-conserving surgery is the preferred surgical treatment for early breast cancer in developed countries, while mastectomy is still more favoured by most centres in developing countries.
To report some quality data on breast cancer surgeries from a sub-urban tertiary hospital in Nigeria.
Retrospective analysis.
We retrospectively reviewed all breast cancer surgeries performed between January 2018 and December 2022 at the Irrua Specialist Teaching Hospital.
A total of 105 female patients underwent breast cancer surgery. Their ages ranged between 27 and 85 years, with a mean of 48.8 years (SD = 12.2). The mean duration of symptoms before presentation was 12.3 ± 17.8 months (1-120 months), with 15.2% presenting with stage I and II disease and 84.7% presenting with stage III and IV disease. Invasive carcinoma NST was the most common histological type in 78 (74.3%) patients. The cancers were predominantly high grade (42.3%) and triple negative (41.5%). Only 9.5% of the patients had breast-conserving surgery, the others had mastectomy. Sixty-three patients (60%) received neoadjuvant chemotherapy while only 25.7% of patients had documented evidence of the completion of adjuvant radiotherapy.
The rate of breast-conserving surgery in this study was extremely low. This could be attributed to the advanced stage at presentation, predominance of aggressive tumours, limited access to radiation therapy, status of the medical system, and patient preferences.
乳腺癌的手术治疗包括改良根治性乳房切除术或保守治疗方法。在发达国家，保乳手术是早期乳腺癌的首选手术治疗方式，而在发展中国家，大多数中心仍更倾向于乳房切除术。
报告尼日利亚一家城郊三级医院乳腺癌手术的一些质量数据。
回顾性分析。
我们回顾性分析了2018年1月至2022年12月在伊鲁阿专科医院进行的所有乳腺癌手术。
共有105名女性患者接受了乳腺癌手术。她们的年龄在27岁至85岁之间，平均年龄为48.8岁（标准差=12.2）。就诊前症状的平均持续时间为12.3±17.8个月（1 - 120个月），15.2%的患者表现为I期和II期疾病，84.7%的患者表现为III期和IV期疾病。浸润性癌非特殊类型是78例（74.3%）患者中最常见的组织学类型。这些癌症主要为高级别（42.3%）和三阴性（41.5%）。只有9.5%的患者接受了保乳手术，其他患者接受了乳房切除术。63名患者（60%）接受了新辅助化疗，而只有25.7%的患者有辅助放疗完成的记录证据。
本研究中保乳手术的比例极低。这可能归因于就诊时的晚期阶段、侵袭性肿瘤的占主导、放疗可及性有限、医疗系统状况以及患者偏好。
